ID   DLD-2
AC   CVCL_Y034
SY   DLD2
DR   Wikidata; Q54831169
RX   PubMed=7139607;
RX   PubMed=7247963;
RX   PubMed=8422623;
CC   Doubling time: ~50 hours (PubMed=7139607); 48 hours (PubMed=7247963).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
RX   PubMed=7139607;
RA   Dexter D.L., Spremulli E.N., Matook G.M., Diamond I., Calabresi P.;
RT   "Inhibition of the growth of human colon cancer xenografts by polar
RT   solvents.";
RL   Cancer Res. 42:5018-5022(1982).
//
RX   PubMed=7247963; DOI=10.1016/0006-2952(81)90167-2;
RA   Crabtree G.W., Dexter D.L., Stoeckler J.D., Savarese T.M., Ghoda L.Y.,
RA   Rogler-Brown T.L., Calabresi P., Parks R.E. Jr.;
RT   "Activities of purine-metabolizing enzymes in human colon carcinoma
RT   cell lines and xenograft tumors.";
RL   Biochem. Pharmacol. 30:793-798(1981).
//
RX   PubMed=8422623; DOI=10.1002/1097-0142(19930115)71:2<315::AID-CNCR2820710208>3.0.CO;2-B;
RA   Tibbetts L.M., Doremus C.M., Tzanakakis G.N., Vezeridis M.P.;
RT   "Liver metastases with 10 human colon carcinoma cell lines in nude
RT   mice and association with carcinoembryonic antigen production.";
RL   Cancer 71:315-321(1993).
//